Short answer
Ginkgo Bioworks Holdings, Inc. (DNA) filed an 8-K current report with the SEC on July 30, 2026 reporting Item 7.01 (Regulation FD Disclosure). Q2 2026 business-performance presentation scheduled for August 5, 2026, at 4:30 p.m. ET.
Ginkgo Bioworks Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Q2 2026 business-performance presentation scheduled for August 5, 2026, at 4:30 p.m. ET
- Investor Q&A and webcast access through Ginkgo’s investor-relations website
- Disclosure signals upcoming management commentary on quarter ended June 30, 2026
- Investors should monitor Ginkgo’s SEC filings, website, blog, and social channels for potentially material updates
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ginkgo Bioworks Holdings, Inc. 8-K filings
Get the next DNA 8-K as it lands
Follow DNA for push alerts, or ask the research agent what this filing means.